Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Novartis strengthens autoimmune indications for Cosentyx

Data shows its IL-17A inhibitor can reduce structural disease progression

- PMLiVE

MorphoSys appoints Dr Markus Enzelberger as CSO

He succeeds Dr Marlies Sproll who resigns

- PMLiVE

Revolutionising how healthcare is delivered

The big technology shift sweeping the global connection of healthcare

- PMLiVE

Porterhouse Medical appoints new talent manager

Jan Coetzee joins the team

Bristol-Myers Squibb (BMS) building

BMS’ Opdivo/Yervoy combination demonstrates OS benefit

Better kidney cancer symptom control reported versus sunitinib was also reported

- PMLiVE

Warning signs

Making the most of multichannel marketing

- PMLiVE

Reig Jofre bolsters its senior team

Gabriel Roig and Roser Gomila join as COO and CFO, respectively

- PMLiVE

Boehringer builds evidence base for its Humira biosimilar

Cyltezo shows clinical equivalence to AbbVie's blockbuster in a late-stage trial

Nobody knew healthcare was so complicated

short term and long term solutions

- PMLiVE

Abbott launches Bluetooth cardiac monitor Confirm RX in the US

The device sits under the patient’s skin and connects to the firm's myMerlin app

- PMLiVE

Global customer research in healthcare: 10 tips for capturing insights that matter

What makes a strong brand? One global core coupled with sensitivity to regions and countries. In part two of our series on customer insight and behaviour change, we share our...

Blue Latitude Health

dengue fever mosquito

Takeda dengue vaccine data looks good as it chases Sanofi

TAK-003 achieved a 71% reduction in developing the virus compared to placebo

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links